​

Natera (NTRA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NTRA Stock Forecast

Natera (NTRA) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $258.78, with a high of $275.00 and a low of $220.00. This represents a -0.75% decline from the last price of $260.74.

$50 $100 $150 $200 $250 $300 High: $275 Avg: $258.78 Low: $220 Last Closed Price: $260.74

NTRA Stock Rating

Natera stock's rating consensus is Buy, based on 27 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 24 Buy (88.89%), 3 Hold (11.11%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 27 0 3 24 Strong Sell Sell Hold Buy Strong Buy

NTRA Price Target Upside V Benchmarks

TypeNameUpside
StockNatera-0.75%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks11.63%

Price Target Trends

1M3M12M
# Anlaysts5919
Avg Price Target$265.00$258.78$248.11
Last Closing Price$260.74$260.74$260.74
Upside/Downside1.63%-0.75%-4.84%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 264132--19
May, 264132--19
Apr, 265122--19
Mar, 265132--20
Feb, 265132--20
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 24, 2026BTIG$275.00$260.725.48%5.47%
Jun 24, 2026UBS$260.00$234.7610.75%-0.28%
Jun 23, 2026BTIG$270.00$234.7615.01%3.55%
Jun 11, 2026Dan LeonardRBC Capital$275.00$219.2325.44%5.47%
Jun 05, 2026Evie KosloskyGoldman Sachs$245.00$222.1010.31%-6.04%
May 12, 2026Piper Sandler$249.00$199.1425.04%-4.50%
May 08, 2026Robert W. Baird$265.00$201.1331.76%1.63%
May 08, 2026Evercore ISI$270.00$200.2034.87%3.55%
May 08, 2026Brandon CouillardWells Fargo$220.00$219.820.08%-15.62%
Jan 05, 2026Guggenheim$270.00$230.6517.06%3.55%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 23, 2026BTIGBuyBuyhold
Jun 11, 2026RBC CapitalOutperformOutperforminitialise
Jun 05, 2026Goldman SachsNeutralinitialise
May 12, 2026Piper SandlerOverweightOverweighthold
May 08, 2026Evercore ISIOutperformOutperformhold
Apr 14, 2026William BlairOutperforminitialise
Jan 12, 2026Canaccord GenuityBuyBuyhold
Jan 07, 2026Cowen & Co.BuyBuyhold
Jan 07, 2026CitigroupBuyinitialise
Jan 05, 2026GuggenheimBuyBuyhold

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 $1 $2 $3 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-5.21$-5.57$-3.78$-1.53$-1.52---
Avg Forecast$-5.02$-5.60$-3.96$-1.50$-1.20$0.02$0.98$1.46
High Forecast$-4.90$-5.26$-3.87$-1.22$-0.79$0.37$2.21$1.53
Low Forecast$-5.32$-5.85$-4.05$-1.61$-1.51$-0.15$0.18$1.33
Surprise %3.78%-0.54%-4.55%2.00%26.67%---

Revenue Forecast

$500M $1B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$625.49M$820.22M$1.08B$1.70B$2.31B---
Avg Forecast$621.43M$819.43M$1.07B$1.65B$1.82B$2.14B$2.46B$2.68B
High Forecast$650.44M$846.85M$1.09B$1.66B$1.88B$2.15B$2.46B$2.79B
Low Forecast$610.12M$780.38M$1.06B$1.64B$1.78B$2.14B$2.45B$2.50B
Surprise %0.65%0.10%1.17%2.72%26.80%---

Net Income Forecast

$-600M $-420M $-240M $-60M $120M $300M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-471.72M$-547.80M$-434.80M$-190.43M$-208.16M---
Avg Forecast$-398.29M$-395.34M$-499.34M$-162.83M$-145.21M$33.61M$168.67M$167.89M
High Forecast$-318.63M$-316.27M$-399.47M$-140.20M$-90.38M$42.22M$253.93M$176.39M
Low Forecast$-477.94M$-474.40M$-599.21M$-185.46M$-173.31M$-17.72M$20.83M$152.77M
Surprise %18.44%38.57%-12.93%16.95%43.35%---

NTRA Forecast FAQ

Is Natera stock a buy?

Natera stock has a consensus rating of Buy, based on 27 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 24 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Natera is a favorable investment for most analysts.

What is Natera's price target?

Natera's price target, set by 27 Wall Street analysts, averages $258.78 over the next 12 months. The price target range spans from $220 at the low end to $275 at the high end, suggesting a potential -0.75% change from the previous closing price of $260.74.

How does Natera stock forecast compare to its benchmarks?

Natera's stock forecast shows a -0.75% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (11.63%).

What is the breakdown of analyst ratings for Natera over the past three months?

  • June 2026: 21.05% Strong Buy, 68.42% Buy, 10.53% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 21.05% Strong Buy, 68.42% Buy, 10.53% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 26.32% Strong Buy, 63.16% Buy, 10.53% Hold, 0% Sell, 0% Strong Sell.

What is Natera’s EPS forecast?

Natera's average annual EPS forecast for its fiscal year ending in December 2026 is $0.02, marking a -101.32% decrease from the reported $-1.52 in 2025. Estimates for the following years are $0.98 in 2027, and $1.46 in 2028.

What is Natera’s revenue forecast?

Natera's average annual revenue forecast for its fiscal year ending in December 2026 is $2.14B, reflecting a -7.05% decrease from the reported $2.31B in 2025. The forecast for 2027 is $2.46B, and $2.68B for 2028.

What is Natera’s net income forecast?

Natera's net income forecast for the fiscal year ending in December 2026 stands at $33.61M, representing a -116.14% decrease from the reported $-208M in 2025. Projections indicate $168.67M in 2027, and $167.89M in 2028.